Related Experiment Video
Updated: Nov 1, 2025

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Fermin Person1, Sara C Meyer2, Helmut Hopfer1
1Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Schönbeinstrasse 40, 4031, PathologyBasel, Switzerland.
Abstract:
Myeloproliferative neoplasms (MPN) are a heterogeneous group of hematological disorders presenting with an increased proliferation in one or several hematological cell lines. Renal manifestations of MPN have not been fully characterized so far. To morphologically assess the potential renal involvement in MPN patients, we analyzed histomorphological findings of a post-mortem cohort (n = 57) with a disease history of Philadelphia-negative MPN including polycythaemia vera, primary myelofibrosis, essential thrombocythemia, or chronic myelomonocytic leukemia (CMML). Seven (12.2%) patients presented with a pattern of diffuse glomerulosclerosis not attributable to diabetic or hypertensive nephropathy. Weak C4d staining suggestive for chronic thrombotic microangiopathy (TMA) was observed in 4/7 cases. Glomerulonephritis was excluded by light microscopy and immunohistochemistry. Patients with a pattern of diffuse glomerulosclerosis did not differ from the rest of the cohort regarding MPN subtype, disease duration, age, or sex. No significant proteinuria had been observed before death. Further findings attributed to MPNs were extramedullary hematopoiesis (n = 5; 8.8%) and tumor involvement in advanced disease (n = 4; 7.0%). Other common findings included arteriolosclerosis (n = 18; 31.6%) and signs of shock (n = 8; 14.0%). To our knowledge, this study is so far the largest investigating renal findings in MPN patients. There may be a causal relationship between idiopathic diffuse glomerular sclerosis and MPN, although its clinical significance and pathophysiology remain uncertain with TMA probably being relevant in a subgroup of cases. Our findings demonstrate the spectrum of renal findings in MPN from early to terminal disease of which hematologists should be aware of in daily clinical practice.
Insights
Myeloproliferative neoplasms (MPN) are linked to kidney issues like diffuse glomerulosclerosis. This study highlights potential MPN-related renal changes, including thrombotic microangiopathy, for clinicians to consider.
Area of Science:
- Nephrology
- Hematology
- Pathology
Background:
- Myeloproliferative neoplasms (MPN) are hematological disorders characterized by increased proliferation of blood cell lines.
- Renal manifestations in MPN patients are not well-characterized.
- Understanding kidney involvement is crucial for comprehensive MPN patient care.
Purpose of the Study:
- To morphologically assess renal involvement in patients with Philadelphia-negative MPN.
- To identify histopathological patterns of kidney damage in a post-mortem cohort.
- To investigate potential links between MPN and specific renal pathologies.
Main Methods:
- Analysis of histomorphological findings in a post-mortem cohort of 57 MPN patients.
- Inclusion of MPN subtypes: polycythemia vera, primary myelofibrosis, essential thrombocythemia, and CMML.
- Exclusion of diabetic or hypertensive nephropathy; assessment for C4d staining and glomerulonephritis.
Main Results:
- 12.2% of patients showed diffuse glomerulosclerosis unrelated to diabetes or hypertension.
- Chronic thrombotic microangiopathy (TMA) was suggested by C4d staining in 4/7 cases with glomerulosclerosis.
- Other findings included extramedullary hematopoiesis (8.8%), tumor involvement (7.0%), arteriolosclerosis (31.6%), and signs of shock (14.0%).
Conclusions:
- A potential causal relationship exists between idiopathic diffuse glomerular sclerosis and MPN, possibly involving TMA.
- The clinical significance and pathophysiology of these renal findings require further investigation.
- Hematologists should be aware of the spectrum of renal findings in MPN patients.
More Related Videos
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018